169280-33-5 Usage
Uses
Used in Pharmaceutical Industry:
A,A-DIMETHYL-4-[4-[4-(HYDROXYDIPHENYL METHYL)-1-PIPERIDINYL]-1-OXOBUTYL]PHENYL ACETIC ACID METHYL ESTER HYDROCHLORIDE is used as a pharmaceutical intermediate for its potential role in the development of new drugs. Its unique structure, including the piperidine ring and phenylacetic acid group, may offer specific pharmacological properties that could be harnessed in medicinal chemistry.
Used in Chemical Synthesis:
In the field of chemical synthesis, A,A-DIMETHYL-4-[4-[4-(HYDROXYDIPHENYL METHYL)-1-PIPERIDINYL]-1-OXOBUTYL]PHENYL ACETIC ACID METHYL ESTER HYDROCHLORIDE serves as a chemical reagent. Its complex molecular structure allows it to participate in various synthetic processes, potentially leading to the creation of new compounds with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 169280-33-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,2,8 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 169280-33:
(8*1)+(7*6)+(6*9)+(5*2)+(4*8)+(3*0)+(2*3)+(1*3)=155
155 % 10 = 5
So 169280-33-5 is a valid CAS Registry Number.
InChI:InChI=1/C33H39NO4.ClH/c1-32(2,31(36)38-3)26-18-16-25(17-19-26)30(35)15-10-22-34-23-20-29(21-24-34)33(37,27-11-6-4-7-12-27)28-13-8-5-9-14-28;/h4-9,11-14,16-19,29,37H,10,15,20-24H2,1-3H3;1H
169280-33-5Relevant academic research and scientific papers
Intermediates useful for the preparation of antihistaminic piperidine derivatives
-
Page column 103-104, (2010/01/30)
The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula whereinW represents —C(=O)— or —CH(OH)—;R1 represents hydrogen or hydroxy;R2 represents hydrogen;R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2;n is an integer of from 1 to 5;m is an integer 0 or 1;R3 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched each of A is hydrogen or hydroxy; and pharmaceutically acceptable salts and individual optical isomers thereof,with the proviso that where R1 and R2 are taken together to form a second bond between the carbon atoms bearing R1 and R2 or where R1 represented hydroxy, m is an integer 0.
